FDA Approved: DSUVIA — Original Application (AcelRx Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved DSUVIA (sufentanil) from AcelRx as an original NDA for the management of acute postoperative pain in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• DSUVIA (SUFENTANIL)

Snippet

ORIG AP for DSUVIA (SUFENTANIL)